Abstract: A method includes providing, in accordance with a memory component activation sequence, a first activation power to a first memory component of a plurality of memory components for a first time period, where the first activation power is provided in the absence of providing an activation power to at least one other memory component of the plurality of memory components during the first time period. The method includes providing, in accordance with the memory component activation sequence, a second activation power to a second memory component for a second time period.

Abstract: Provided herein are methods, compositions and articles of manufacture for use in connection with cell therapy involving the administration of one or more doses of a therapeutic T cell composition. The cells of the T cell composition express recombinant receptors such as chimeric receptors, e.g. chimeric antigen receptors (CARs) or other transgenic receptors such as T cell receptors (TCRs). Features of the provided embodiments, including the numbers of cells or units of cells administered and/or the potency of administered cells, provide various advantages, such as lower risk of toxicity in subjects administered the T cell compositions.

Abstract: Portable ear-worn acoustic devices having a wingtip anchor for improved anchoring for active users and to accommodate a wide range of ear sizes and shapes are provided herein. Such acoustic devices an include an earbud device body and a wingtip anchor that extends from an outer face of the device body. The wingtip anchor can include a base portion and a protruding portion that extends upwards and is angled or curved inwardly so as to engage the upper concha of the ear. The wingtip anchor can be flexible so that engagement of a distal portion of the anchor exerts an inwardly directed spring force on the device body to maintain the earbud device body within the ear. Such acoustic devices can further include a multi-function button that is integrated with the wingtip anchor such that the base portion of the wingtip anchor is a faceplate for the multi-function button.

Abstract: A method of detecting and responding to a visitor to a smart home environment via an electronic greeting system of the smart home environment, including determining that a visitor is approaching an entryway of the smart home environment; initiating a facial recognition operation while the visitor is approaching the entryway; initiating an observation window in response to the determination that a visitor is approaching the entryway; obtaining context information from one or more sensors of the smart home environment during the observation window; and at the end of the time window, initiating a response to the detected approach of the visitor based on the context information and/or an outcome of the facial recognition operation.

Abstract: Described herein are orally-bioavailable nucleoside analogs and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of coronavirus infections, including SARS-CoV-2 infection.

Abstract: The present disclosure generally describes user interfaces related to time. In accordance with embodiments, user interfaces for displaying and enabling an adjustment of a displayed time zone are described. In accordance with embodiments, user interfaces for initiating a measurement of time are described. In accordance with embodiments, user interfaces for enabling and displaying a user interface using a character are described. In accordance with embodiments, user interfaces for enabling and displaying a user interface that includes an indication of a current time are described. In accordance with embodiments, user interfaces for enabling configuration of a background for a user interface are described. In accordance with embodiments, user interfaces for enabling configuration of displayed applications on a user interface are described.

Abstract: The present disclosure provides broad-spectrum carbapenem derivatives and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such derivatives and/or compositions.

Abstract: A modular valve tree may have two or more blocks. Additionally, a first block may have a flow passage therethrougt, with an inlet and an outlet and a second block may have a flow passage therethrough with including an inlet and an outlet. Further, an insert may be provided comprising sealing elements. The insert may be partially disposed within each of the first block and the second block and the insert has a throughbore fluidly connecting the first block outlet to the second block inlet. Furthermore, the sealing elements are configured to seal external surfaces of the insert against an internal surface of the respective flow passages. A retention system may retain the blocks in position and compress and engage one or more of the sealing elements.

Abstract: Described herein are certain boron-containing compounds, compositions, preparations and their use as modulators of the transpeptidase function of bacterial penicillin-binding proteins and as antibacterial agents. In some embodiments, the compounds described herein inhibit penicillin-binding proteins. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.

Abstract: The present invention relates to combination treatments for cystic fibrosis, particularly combinations of modulators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and gene therapy.

Abstract: Conventionally, software-based services that utilize satellites are manually and painstakingly configured, provisioned, activated, and calibrated, because the complexity and variability of satellite links prevent automated and scalable service orchestration. Accordingly, systems and processes are disclosed for automated and scalable orchestration of services that utilize satellite links. In response to a service request, comprising a service definition for an end-to-end service, parameter(s) of a satellite link that satisfies the service definition may be calculated. These parameter(s) may be used to select a configuration for a satellite-network service chain, comprising a plurality of virtual network functions, from a service catalog. The satellite-network service chain may then be instantiated, within a cloud infrastructure, using the selected configuration.

Abstract: The present disclosure relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.

Abstract: A harness apparatus for use with a head-mounted display device is disclosed. In at least one embodiment, the apparatus provides a pair of display connector portions positioned on opposing left and right sides of the display device. A harness assembly provides at least one elongate primary head strap for engagement about a user’s head, with opposing terminal ends of the at least one primary head strap being positioned proximal a left temple and a right temple, respectively, of the user’s head, and providing a pair of strap connector portions configured for removable engagement with the pair of display connector portions. The harness assembly further provides a gasket extending between the strap connector portions and configured for being positionable in contact with a face of the user so as to be sandwiched between the display device and the user’s face when the display device is engaged with the harness assembly.

Abstract: Various systems, devices and methods automatically identify advertisements or other portions of television or other media content prior to broadcast using automated content analysis. Information about identified content may be used for any number of different purposes, including advertisement identification; advertisement replacement; second screen browsing or augmentation of identified content; tracking of times or places that ads or other content are viewed; and many others.

Abstract: A harness apparatus for use with a head-mounted display device is disclosed. In at least one embodiment, the apparatus provides a pair of display connector portions positioned on opposing left and right sides of the display device. A harness assembly provides at least one elongate primary head strap for engagement about a user's head, with opposing terminal ends of the at least one primary head strap being positioned proximal a left temple and a right temple, respectively, of the user's head, and providing a pair of strap connector portions configured for removable engagement with the pair of display connector portions. The harness assembly further provides a gasket extending between the strap connector portions and configured for being positionable in contact with a face of the user so as to be sandwiched between the display device and the user's face when the display device is engaged with the harness assembly.

Abstract: The present disclosure relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.

Abstract: A harness apparatus for use with a head-mounted display device is disclosed. In at least one embodiment, the apparatus provides a pair of display connector portions positioned on opposing left and right sides of the display device. A harness assembly provides at least one elongate primary head strap for engagement about a user's head, with opposing terminal ends of the at least one primary head strap being positioned proximal a left temple and a right temple, respectively, of the user's head, and providing a pair of strap connector portions configured for removable engagement with the pair of display connector portions. The harness assembly further provides a gasket extending between the strap connector portions and configured for being positionable in contact with a face of the user so as to be sandwiched between the display device and the user's face when the display device is engaged with the harness assembly.